Database of Nasopharyngeal Carcinoma Early Screening Microbiome-Based(NPC-MB)
name：Database of Nasopharyngeal Carcinoma Early Screening Microbiome-Based(NPC-MB)
Nasopharyngeal cancer is a malignant tumor with high clinical incidence and tops the list of malignant tumors in otolaryngology. Because of the deep concealment of the nasopharynx, the very complex neighboring relationship with the periphery and the variability of clinical manifestations, early diagnosis is very difficult and the best treatment time is easily missed due to missed diagnosis or misdiagnosis. Due to the unique anatomical location and biological behavior of nasopharyngeal cancer, synchronous radiotherapy has been the main treatment for nasopharyngeal cancer, followed by radiotherapy, chemotherapy, targeted therapy, surgery and Chinese medicine.
In order to integrate data resources and results of microbial studies in nasopharyngeal cancer and to promote related research, a literature review and information extraction analysis were conducted, leading to the construction of a nasopharyngeal cancer microbiome tumor early screening database to assist in early diagnosis and treatment. The database covers microbial names and classifications, sample types, regions, references and their links. The tumor microbiome may be used as a prognostic or predictive tool, which may also help in the development of new anti-cancer drugs.